Brookwood Investment Group LLC Grows Stock Holdings in Cardinal Health, Inc. $CAH

Brookwood Investment Group LLC increased its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 128.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,853 shares of the company’s stock after buying an additional 2,728 shares during the period. Brookwood Investment Group LLC’s holdings in Cardinal Health were worth $997,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. SJS Investment Consulting Inc. boosted its holdings in Cardinal Health by 1,363.6% during the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after buying an additional 150 shares in the last quarter. Aventura Private Wealth LLC purchased a new stake in Cardinal Health during the fourth quarter worth about $25,000. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% during the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares in the last quarter. JPL Wealth Management LLC purchased a new stake in Cardinal Health during the third quarter worth about $31,000. Finally, Turning Point Benefit Group Inc. purchased a new stake in Cardinal Health during the third quarter worth about $31,000. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $215.32 on Friday. Cardinal Health, Inc. has a 12-month low of $128.44 and a 12-month high of $233.60. The company has a market capitalization of $50.67 billion, a PE ratio of 30.98, a price-to-earnings-growth ratio of 1.39 and a beta of 0.64. The firm’s 50-day moving average is $217.84 and its two-hundred day moving average is $200.49.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.32. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company had revenue of $65.63 billion for the quarter, compared to the consensus estimate of $64.88 billion. During the same quarter in the prior year, the firm earned $1.93 earnings per share. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. On average, analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Wednesday, April 1st. Cardinal Health’s payout ratio is currently 29.35%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on CAH. Citigroup raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $190.00 to $244.00 in a report on Friday, January 9th. Barclays boosted their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, February 24th. Zacks Research raised shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, February 12th. Wall Street Zen raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, April 4th. Finally, Leerink Partners reaffirmed an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $244.33.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.